Genmab A (GMAB) Other Non-Current Liabilities: 2018-2020
Historic Other Non-Current Liabilities for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $114,830.
- Genmab A's Other Non-Current Liabilities fell 21.89% to $114,830 in Q4 2020 from the same period last year, while for Dec 2020 it was $114,830, marking a year-over-year decrease of 21.89%. This contributed to the annual value of $114,830 for FY2020, which is 21.89% down from last year.
- Latest data reveals that Genmab A reported Other Non-Current Liabilities of $114,830 as of FY2020, which was down 21.89% from $147,010 recorded in FY2019.
- Genmab A's 5-year Other Non-Current Liabilities high stood at $157,354 for FY2018, and its period low was $114,830 during FY2020.
- Moreover, its 3-year median value for Other Non-Current Liabilities was $147,010 (2019), whereas its average is $139,732.
- Data for Genmab A's Other Non-Current Liabilities shows a maximum YoY decreased of 21.89% (in 2020) over the last 5 years.
- Yearly analysis of 3 years shows Genmab A's Other Non-Current Liabilities stood at $157,354 in 2018, then dropped by 6.57% to $147,010 in 2019, then dropped by 21.89% to $114,830 in 2020.